LNC 31 (+0.98%)
US5341871094Drug ManufacturersDrug Manufacturers - Specialty & Generic

Linc (LNC) Stock Highlights

31 | +0.98%
2024-12-21 02:01:03
Linc AB is an investor in product-oriented companies in the Nordic Life Science industry. It mainly invest in and develop small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals.

Statistics

Range Today
30.11 31.69
Volume Today 3.67M
Range 1 Year
25.1 36.98
Volume 1 Year 402.25M
Range 3 Year
18.5 76.4
Volume 3 Year 1.63B
Range 10 Year
16.11 86.68
Volume 10 Year 4.83B

Highlights

Market Capitalization 5.94B (mid)
Floating Shares 168.9M
Current Price 31
Price To Earnings 24.84
Price To Revenue -1.88
Price To Book 0.74
Earnings Per Share 1.42
Dividend Yield 5.1%
Dividend Per Share 1.8
Payout Ratio 125.87%

Performance

Latest +0.98%
1 Month -9.62%
3 Months -2.39%
6 Months -0.77%
1 Year +12.36%
3 Years -52.08%
5 Years -48.9%
10 Years -46.84%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.